Affymetrix Inc., which makes genetic testing technology, reported a narrower first-quarter loss as revenue improved and it cut back on costs. The company's sales outlook fell shy of Wall Street expectations, and investors sent...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Affymetrix Shares Tumble on 1Q Results, Outlook
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account